Owkin Licenses K Pro, Patient Data to Servier for Oncology Research
This story is from 2026-09-11. It is preserved in the archive; the latest stories are on the live feed.
Owkin announced an agreement on September 11, 2026, to license K Pro, its AI scientist for biopharma research, together with multimodal patient data to Servier, an independent international pharmaceutical group governed by a foundation, to advance Servier's oncology research. What the License Cover…
Read the full story at Unite.AI ↗
Timeline · 1 report
- 2026-09-11 12:26 · Unite.AI
Owkin Licenses K Pro, Patient Data to Servier for Oncology Research